Han-Po Shih

Title: The Innovative Contributions of Han-Po Shih

Introduction

Han-Po Shih is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of immunotherapy, particularly through his work on antibodies. With a total of 3 patents to his name, his innovations are paving the way for advancements in medical treatments.

Latest Patents

One of Han-Po Shih's latest patents is titled "Anti-interferon gamma antibodies and uses thereof." This patent provides an anti-INF-γ antibody, along with a composition comprising the antibody and a pharmaceutical application for treating IFN-γ mediated syndrome. Another significant patent is "Antibodies to granulocyte-macrophage colony stimulating factor and uses thereof." This patent discloses anti-GM-CSF antibodies that can bind to human GM-CSF and block its biological activities. It also includes pharmaceutical compositions comprising these antibodies and their therapeutic and diagnostic uses.

Career Highlights

Han-Po Shih is currently associated with Elixiron Immunotherapeutics (Hong Kong) Limited, where he continues to innovate in the field of immunotherapy. His work is crucial in developing new treatments that can improve patient outcomes.

Collaborations

He collaborates with talented individuals such as Cheng-Lun Ku and Jing-Ya Ding, contributing to a dynamic research environment that fosters innovation.

Conclusion

Han-Po Shih's contributions to immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to inspire advancements in medical science and treatment options.